Drug Database · Clinicians

Tolnaftate

Brands (4) Healthcare Tinea, Dermactin, Tinactin…Show all

US brand (reference label): Mycozyl AL; not a Philippine-registered brand.

Antifungal; Anti-fungal PH FDA category

Rx · Prescription drugOTC · Over-the-counter8 PH products
Dispensing: Over-the-counter (OTC) · Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 07edd043-4ac4-b2de-e063-6394a90af25d, version date October 17, 2023 (Mycozyl AL · PURETEK CORPORATION). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • INDICATIONS AND USAGE: Mycozyl AL™ is effective in the treatment of most skin infections such as athlete's foot (tinea pedis) and ringworm (tinea corporis).
US FDA label
Full indications and usage US FDA label

INDICATIONS AND USAGE: Mycozyl AL™ is effective in the treatment of most skin infections such as athlete's foot (tinea pedis) and ringworm (tinea corporis). Mycozyl AL™ has been designed to reach skin areas around and under the nails while it relives burning, cracking, scaling and discomfort which accompany these conditions.

Mycozyl AL™ is an antifungal that works by preventing and eliminating the growth of fungus on fingers, toes and around the nails. It eliminates and helps stop the spread of fungal infections on cuticles around nail edges and under the nail tips where reachable with applicator brush. Mycozyl AL™ cures and prevents fungal infections from coming back with daily use.

Contraindications

CONTRAINDICATIONS: Tolnaftate topically applied is not likely to affect drugs taken or injected, but many drugs can interact with each other.

US FDA label

Dosing: Adult

Dosage and administration (US label) US FDA label

DOSAGE AND ADMINISTRATION:

  • Clean the affected area with soap and warm water and dry thoroughly
  • Apply a thin layer of product over affected area twice daily (morning and night) paying special attention to the edges of the nail, cuticles and skin around the nails or as directed by a doctor
  • The brush applicator allows for easy application on skin around the nail and cuticle areas.
  • For athlete's foot, pay special attention to spaces between the toes, wear well-fitting,ventilated shoes, and change shoes and socks at least once daily.
  • For athlete's foot and ringworm, use daily for 4 weeks.
  • Supervise children in the use of this product. Use under the direction of a licensed medical practitioner. Call your doctor about side effects. To report side effects, call PureTek Corporation at 1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 1

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosing: Pediatric

Pediatric use (US label) US FDA label

Pediatric Use: Safety and effectiveness have not been established in pediatric patients less than 2 years of age.

Dosage forms

Philippines

  • Ointment: 10 mg/g
  • ) cream: 10 mg/g
  • Cream: 10 mg/g
  • Topical cream: 10 mg
  • Topical solution: 10 mg/mL

Registered products in the Philippines

8 products registered with the Food and Drug Administration (FDA) Philippines list Tolnaftate as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products8
Philippine FDA-registered products for Tolnaftate
Package insert
DermactinTolnaftate
10 mg/g OintmentLaminated Aluminum Tube x 10 g, 15 g, and 30 g (Box of 1's)
OTC
Interphil Laboratories, Inc.Philippines
—
DRP-1910
Oct 3, 2028
Healthcare TineaTolnaftate
1% (10 mg/g) CreamAluminum Tube x 15 g (Box of 1's)
Rx
Lloyd Laboratories, Inc.Philippines
—
DR-XY39339 (For Export Only)
Apr 19, 2031
Healthcare TineaTolnaftate
10 mg/mL (1% w/v) Topical SolutionLDPE White Plastic Bottle x 30 mL (Box of 1's)
Rx
Lloyd Laboratories, Inc.Philippines
—
DR-XY42139
Jun 20, 2028
NoneTolnaftate
10 mg/g OintmentLaminated Aluminum Tube x 10 g and 30 g (Box of 1's)
OTC
Interphil Laboratories, Inc.Philippines
Neodrug Inc.
DRP-1910-02
Oct 3, 2028
NoneTolnaftate
10 mg/g OintmentLaminated Aluminum Tube x 15 g (Box of 1's)
OTC
Interphil Laboratories, Inc.Philippines
Ritemed Phils., Inc.
DRP-1910-03
Oct 3, 2028
TinactinTolnaftate
10 mg/g OintmentAluminum Tube with PP Cap x 5 g (Box of 1's)
Rx
Interphil Laboratories, Inc.Philippines
Trader: Bayer Philippines, Inc.
DR-XY47269
May 11, 2031
TolnactinTolnaftate
10 mg/g (1% w/w) Cream15 g Collapsible Aluminum Tube (Box of 1's)
Rx
Lloyd Laboratories, Inc.Philippines
TGP Pharma, Inc.Trader: D.B. Manix International, Inc.
DR-XY40290
Nov 14, 2031
UnbrandedTolnaftate
10 mg (1% w/w) Topical CreamCollapsible Aluminum Tube x 10 g (Box of 1's)
Rx
Lloyd Laboratories, Inc.Bulacan
—
DR-XY40458
Dec 26, 2031

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

WARNINGS: For External Use Only. Not For Ophthalmic Use

Adverse reactions

Adverse reactions (US label) US FDA label

ADVERSE REACTIONS: For athlete’s foot and ringworm - if irritation occurs or there is no improvement within 4 weeks. For prevention of athlete’s foot – if irritation occurs, discontinue use and consult a doctor.

Pregnancy considerations

Pregnancy (US label) US FDA label

Pregnancy: Teratogenic effects - There is currently no published human data available on the teratogenic and fetotoxic effects of tolnaftate.

Breastfeeding considerations

Lactation (US label) US FDA label

Nursing Mothers: Before using this medication while breastfeeding, it is recommended to consult with a healthcare professional.

Pharmacokinetics

Pharmacokinetics (US label) US FDA label

Pharmacokinetics: Tolnaftate is only given topically, and there are no documented reports on its pharmacokinetics and systemic metabolism.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Mycozyl AL · PURETEK CORPORATION [US FDA-approved label, version 1, October 17, 2023]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=07edd043-4ac4-b2de-e063-6394a90af25d
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .